Table 7.
Treatment | CR (mg/dL) | UR (mg/dL) | AST (mg/dL) | ALT (mg/dL) | GGT (mg/dL) | MDA (U/mg protein) | SOD (U/mg protein) | GPX (U/mg protein) |
---|---|---|---|---|---|---|---|---|
NC1 | 0.270e | 4.00b | 183.25c | 7.25c | 17.15c | 2.08c | 248.75a | 48.00a |
PCAFB1 | 0.347a,b | 6.00a | 280.30a | 11.50a | 30.30a | 2.35a | 217.50c | 28.75d |
PCOTA1 | 0.380a | 5.50a,b | 264.17a | 12.25a | 27.30a,b | 2.33a | 220.00b,c | 27.25d |
PCAFB+200 BBR2 | 0.340a,b,c | 4.50a,b | 230.70b | 9.75a,b,c | 24.60b | 2.27a,b | 228.25b,c | 30.00c,d |
PCAFB+400 BBR2 | 0.345b,c,d,e | 4.25b | 196.07c | 8.08b,c | 20.17c | 2.23a,b | 227.00b,c | 31.50c,d |
PCAFB+600 BBR2 | 0.287c,d,e | 4.26b | 183.90c | 7.50b,c | 17.47c | 2.17b,c | 227.75b,c | 38.00b |
PCOTA+200 BBR2 | 0.330a,b,c,d | 5.25a,b | 196.87c | 10.25a,b | 24.17b | 2.28a,b | 221.75b,c | 30.50c,d |
PCOTA+400 BBR2 | 0.305b,c,d,e | 4.25b | 189.72c | 8.05b,c | 19.72c | 2.24a,b | 226.75b,c | 31.75c,d |
PCOTA+600 BBR2 | 0.282d,e | 4.09b | 186.97c | 8.00b,c | 19.47c | 2.23a,b | 230.00b | 35.00b,c |
P-Value | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 0.0009 | 0.0001 | 0.0005 | 0.0001 |
SEM | 0.011 | 0.0346 | 4.714 | 0.585 | 0.79 | 0.02 | 2.52 | 1.21 |
a–eSuperscripts within columns indicate significant differences between treatments (P < 0.05).
Abbreviations: ALT, alanine aminotransferase; AST, aspartate aminotransferase; CR, creatinine; GGT, gamma-glutamyl transferase; GPX, glutathione peroxidase; MDA, malondialdehyde; SOD, superoxide dismutase; UR, urea.
NC, negative control diet with no additives; PCAFB, NC + 2 ppm AFB (positive control AFB); PCOTA, NC + 2 ppm OTA (positive control OTA).
Berberine supplementation (mg/kg diet).